Golden State Wealth Management, LLC Vertex Pharmaceuticals Inc Transaction History
Golden State Wealth Management, LLC
- $673 Billion
- Q1 2025
A detailed history of Golden State Wealth Management, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Golden State Wealth Management, LLC holds 95 shares of VRTX stock, worth $48,402. This represents 0.01% of its overall portfolio holdings.
Number of Shares
95
Previous 658
85.56%
Holding current value
$48,402
Previous $319,000
14338.24%
% of portfolio
0.01%
Previous 0.02%
Shares
9 transactions
Others Institutions Holding VRTX
# of Institutions
1,801Shares Held
224MCall Options Held
1.63MPut Options Held
1.47M-
Capital World Investors Los Angeles, CA28.3MShares$14.4 Billion1.8% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.3MShares$11.9 Billion0.17% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$10.9 Billion0.23% of portfolio
-
State Street Corp Boston, MA12MShares$6.1 Billion0.2% of portfolio
-
Capital Research Global Investors Los Angeles, CA10.4MShares$5.31 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $131B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...